Cronos Group (CRON) Q2 2024 earnings summary

Executive summary

• Q2 2024 net revenue reached a record CAD 27.8 million, up 46% year-over-year, driven by growth in Canada, Israel, Germany, and new UK sales.

• Strategic focus on high-quality cannabis flower and branded products led to market share gains in Canada and Israel, with Spinach, Lord Jones, and PEACE NATURALS brands expanding internationally.

• Expansion of GrowCo facility and its consolidation into financials positions the company for future growth and supply flexibility.

Financial highlights

• Consolidated net revenue was CAD 27.8 million, up 46% year-over-year, mainly from higher cannabis flower and extract sales in Canada and Israel, and new markets.

• Gross profit reached CAD 6.3 million (23% margin), a CAD 3.2 million and 600 bps improvement year-over-year.

• Adjusted EBITDA was negative CAD 11.1 million, a CAD 4.9 million improvement from the prior year.

• Free cash flow was +CAD 8 million, compared to -CAD 12.3 million in Q2 2023.

• Cash and cash equivalents stood at CAD 848 million as of June 30, 2024.

Outlook and guidance

• GrowCo expansion and consolidation expected to drive future growth and provide greater supply flexibility.

• Net change in cash for 2024 now expected to be negative due to the CAD 51 million GrowCo investment.

• Continued focus on cost controls with a 2024 goal of CAD 5–10 million in incremental savings.